The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
about
The significance of tumor-associated immune response in molecular taxonomy, prognosis and therapy of colorectal cancer patientsPrognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon CancerThe intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsHigh myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.Histopathological features predict metastatic potential in locally advanced colon carcinomasThe relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancerThe relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancerThe role of inflammatory cells in fostering pancreatic cancer cell growth and invasionc-MET expression in colorectal adenomas and primary carcinomas with its corresponding metastasesCD33⁺/p-STAT1⁺ double-positive cell as a prognostic factor for stage IIIa gastric cancer.Signal propagation in protein interaction network during colorectal cancer progression.Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer.Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancerDetailed analysis of inflammatory cell infiltration in colorectal cancer.The in situ local immune response, tumour senescence and proliferation in colorectal cancer.Defective generation and maturation of dendritic cells from monocytes in colorectal cancer patients during the course of disease.Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology.Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancerImmune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence.Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era.Macrophages and therapeutic resistance in cancer.The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer.Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study.Microcystin-LR promotes migration and invasion of colorectal cancer through matrix metalloproteinase-13 up-regulation.The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer.Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery.The perioperative immune/inflammatory insult in cancer surgery: Time for intervention?Response to Park et al. reply to 'Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study'.Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer.Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study.Characteristics and significance of colorectal cancer associated lymphoid reaction.TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention.Distribution pattern of tumor associated macrophages predicts the prognosis of gastric cancer.The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
P2860
Q26738665-15D0C1E7-069C-4ACA-864C-DE4A9B6AED7CQ26777108-49FE6D5A-609C-4595-8E24-93FFDA531D3AQ33613578-56228AB6-EDB7-4877-92F3-1E2CA498BF45Q33613591-D2C11768-35A0-474A-AF9D-ED053135C9A1Q34755696-1741D6EA-C0A6-4B0A-934E-080ED33DE59BQ35016109-364B495F-4CF3-4C25-B33F-EC057FFC138DQ35611945-73A14525-59D7-4F46-9F95-2A977F14506BQ35929864-1189CD1A-6076-4C2D-A941-679A0F07E693Q36014349-BE26D9F3-B255-45FF-8BBD-AA3BA4472E6FQ36072807-CA7FBCF7-A6AB-4AB8-98B7-8C8290F96EF7Q36202213-E7396E56-6733-47C8-BFC7-9440FEA7797CQ36352462-3DFBDAF7-BF5C-4435-AC5C-C5D335386FF5Q36651018-F243C99A-0474-411D-B8A0-933A976F1F9DQ36737842-A1A7F70C-09FF-46F5-888E-C5EB8FDD5E33Q36821123-D659259C-00F2-4325-9AC6-9B362EB9BBF7Q37003359-1BF6633F-0E31-47A4-A292-D72416BD45EFQ37214263-182B4C1F-B23E-4AAB-BD07-52CCDD27878AQ37235543-B1ECACD1-2428-48A2-8081-79F8D0B41E54Q37375412-2DE4A621-88A1-45BE-A714-320B3774AB26Q37397201-C0E001DA-A582-4EEC-A20A-BBFF280DCD92Q37722443-04E358A1-5E51-40AA-8465-FF044B8F005AQ37735615-4EF1D256-3168-4B11-973F-56B00638FFFFQ38197678-6F360A9E-E962-4BD3-A940-C07D60BF6F51Q38241953-6839C1F2-896A-4D93-A587-133B2D833399Q38413720-90A4106A-0804-47CC-A698-BF6398FA7011Q38533166-4AB15F39-24D1-4496-8F95-1EDE44B91A60Q38761014-EB618889-6B1B-49FB-8475-74370B0ADBDBQ38897558-E8207581-7BFF-4F3D-B9F0-CFE01BA16D55Q39684656-5987063F-566B-4491-8B75-248CD36697B9Q40339236-DFFC5ACF-535E-4C4C-BDDD-8DBF1D86A085Q40720854-54AD6B6D-1045-4A8E-8B17-8C681ABD9F2EQ41117167-5406524A-046B-4C48-B005-789A225F3834Q41788262-A8758FF9-51EE-4542-B039-2DD8E945573DQ43496654-8BEDADDD-9A4B-4776-9653-A417E33335CAQ43897776-A2723C04-198F-44B9-B5BC-A8CF2C90381BQ44437073-9EF5AF97-9146-4B81-8DB2-415F05B30B5BQ45027953-0D95A01A-1D45-43CB-A590-1CD75A98EF28Q46247691-00FCD962-5FF0-477B-9440-77907966E8E6Q47136843-F8FA928E-51A0-4D66-AF79-29EE73D8F390Q50026722-A9FA6BA4-80D2-4071-B17B-4440FBC4BCD5
P2860
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of the in situ local ...... ry operable colorectal cancer.
@en
The role of the in situ local ...... ry operable colorectal cancer.
@nl
type
label
The role of the in situ local ...... ry operable colorectal cancer.
@en
The role of the in situ local ...... ry operable colorectal cancer.
@nl
prefLabel
The role of the in situ local ...... ry operable colorectal cancer.
@en
The role of the in situ local ...... ry operable colorectal cancer.
@nl
P921
P1476
The role of the in situ local ...... ary operable colorectal cancer
@en
P2093
C S D Roxburgh
P304
P356
10.1016/J.CTRV.2011.09.001
P577
2011-09-25T00:00:00Z